3

OWNERSHIP DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: February 11, 2021
Period of Report: February 11, 2021
Accession Number: 0001104659-21-020783

View Document ↗ View on SEC.gov ↗